−£770
vs Mar 2024Active10671795Private limited companyWarrington
UNIVERSAL CELL THERAPEUTICS LTD.
Significant control: Steven Joseph Mayers (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Universal Cell Therapeutics Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Universal Cell Therapeutics Ltd. sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
UNIVERSAL CELL THERAPEUTICS LTD. is an active private limited company (company number 10671795) incorporated on 15 March 2017, registered in Warrington. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest dormant accounts cover the period ending 31 March 2025, showing net assets of −£770, with 0 employees on average. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the bottom quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
02
Ownership and control
- Mr Steven Joseph Mayers
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 March 20179 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 29 March 2027in 155 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
Not reported the period before| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£770 | — | — | £0 | — | — | 0 |
| 31 March 2024 | −£770 | — | — | £0 | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-770 at 31 March 2025
- Incorporated five or more years agoIncorporated 15 March 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 155 days
- Next accounts duein 67 days
- Accounts period endNet liabilities £770 · dormant accounts
- Accounts period endNet liabilities £770 · dormant accounts
- Incorporated
08
Similar companies in Manchester
- ITREATSKIN LIMITEDRochdale · inc. Feb 2017
- KMX HEALTHCARE LTDStockport · inc. Sept 2016
- SASH VITALITY LTDManchester · inc. Apr 2016
- LIMINAL BIOSCIENCES LIMITEDAltrincham · inc. Dec 2015
- ONE SECOND SUPPLEMENTS LIMITEDStockport · inc. Jun 2018
- PHARMAYOUTH LTD.Manchester · inc. Nov 2015
All companies incorporated on 15 March 2017 · in Mar 2017.
09
Reminders for UNIVERSAL CELL THERAPEUTICS LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.